UCB's Global Corporate Website
Welcome to UCB in the United States

Oct

30

Patients Inspiring Growth at UCB's Bedford Lab

UCB researchers like Jessica Williamson, PhD, come to work driven by a singular purpose – to create value for people living with severe disease. That’s because patients depend on the important work of scientific research to discover new medical innovations that will help them achieve their goals. Read more from Dr. Williamson about why she's passionate about innovating for patients and UCB's growing research presence in the greater Boston area.

Oct

21

Infographic: Seizure Clusters

At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness. Check out the full infographic below.

Oct

21

Disease Spotlight: Seizure Clusters

At UCB, we keep patients at the center - inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We have a rich heritage in epilepsy, and today, we’re shining a spotlight on seizure clusters, which can affect people with uncontrolled epilepsy, to help spread awareness.

Oct

15

Finding the Inspiration to Thrive with nr-axSpA

Learn more about living with non-radiographic axial spondyloarthritis (nr-axSpA) from Chelsea, who recently shared her story.

Oct

09

It’s Time to Come Together to Deliver More for Patients

At UCB, we keep patients at the center of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. Read more from UCB's CEO and Chairman of the Executive Committee, Jean-Christophe Tellier, about why it's time to come together across all healthcare stakeholders to deliver more for patients.

Oct

03

UCB PharmD Fellows Have a Big Impact on Patients

UCB Global Regulatory Affairs Fellows (L to R): Howraa Alasker, PharmD and Tanya Chaudhri, PharmD, RPh

The 2020-2022 UCB Global Regulatory Affairs (GRA) PharmD Fellowship Program, a collaboration with the Industry Pharmacists Organization (IPhO), is a 2-year rotational program located at UCB’s Atlanta campus aimed at growing top regulatory talent for the future. Established in 2017, the Fellowship Program is designed to provide PharmD graduates with the opportunity to learn and experience all aspects of regulatory affairs under the mentorship of experienced preceptors. Applications are being accepted now until November 1, 2019. Learn more about the fellowship from current fellow, Tanya Chaudhri, PharmD, RPh.

Sep

27

Patients at the Heart Now and in the Future

Over the last few weeks, we’ve showcased what drives UCB employees to put patients at the heart of everything they do. We believe our future at UCB has never been brighter thanks to the passionate team of UCB employees who dedicate themselves to delivering what patients value each day.

Sep

24

Disease Spotlight: Immune Thrombocytopenia (ITP)

At UCB, we’re focused on helping patients live their best lives. We aim to connect targeted patient populations to cutting-edge science and, in doing so, deliver improved, differentiated experiences to people with the highest unmet needs. September is Immune Thrombocytopenia (ITP) Awareness month, so we’re shining a spotlight on ITP, a rare disease previously known as idiopathic thrombocytopenic purpura.

Sep

19

Unlocking What’s Possible for Patients Through Tech

UCB is committed to discovering and developing new solutions that transform the lives of people living with severe diseases. For Sr. IT Project Lead, Stayce Murray, technology is a key part of this equation to unlock what’s possible. Read more from Stayce about why she puts patients at the heart of everything she does.

Sep

12

UCB and University of Washington Collaborate on Engaging Community Pharmacists to Improve Care for People Living with Epilepsy

UCB is collaborating with the University of Washington to improve care delivery for people living with epilepsy by engaging community pharmacists.